Cargando…
Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice
Antibodies are principal immune components elicited by vaccines to induce protection from microbial pathogens. In the Thai RV144 HIV-1 vaccine trial, vaccine efficacy was 31% and the sole primary correlate of reduced risk was shown to be vigorous antibody response targeting the V1V2 region of HIV-1...
Autores principales: | Hioe, Catarina E., Li, Guangming, Liu, Xiaomei, Tsahouridis, Ourania, He, Xiuting, Funaki, Masaya, Klingler, Jéromine, Tang, Alex F., Feyznezhad, Roya, Heindel, Daniel W., Wang, Xiao-Hong, Spencer, David A., Hu, Guangnan, Satija, Namita, Prévost, Jérémie, Finzi, Andrés, Hessell, Ann J., Wang, Shixia, Lu, Shan, Chen, Benjamin K., Zolla-Pazner, Susan, Upadhyay, Chitra, Alvarez, Raymond, Su, Lishan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765624/ https://www.ncbi.nlm.nih.gov/pubmed/34986207 http://dx.doi.org/10.1371/journal.ppat.1010183 |
Ejemplares similares
-
Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations
por: Upadhyay, Chitra, et al.
Publicado: (2018) -
Signal peptide of HIV-1 envelope modulates glycosylation impacting exposure of V1V2 and other epitopes
por: Upadhyay, Chitra, et al.
Publicado: (2020) -
Dual Role of HIV-1 Envelope Signal Peptide in Immune Evasion
por: Upadhyay, Chitra, et al.
Publicado: (2022) -
Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies
por: Shen, Guomiao, et al.
Publicado: (2015) -
Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1
por: Hioe, Catarina E., et al.
Publicado: (2023)